Haloub, Radi;
Javid, Farideh A;
Abdul Waheed, Fadi;
Zainab, Nisa;
Khan, Hamza;
Amin, Ibrahim;
Bham, Ammar;
... Sheraz, Aneem; + view all
(2023)
COVID-19 and diabetes in 2020: a systematic review.
Journal of Pharmaceutical Policy and Practice
10.1186/s40545-023-00546-z.
Preview |
Text
Journal of Pharmaceutical Policy and Practice.pdf - Published Version Download (920kB) | Preview |
Abstract
Attempts were made to review the literature on diabetic patients who experience complications when they contract COVID-19, and to determine whether ethnicity and other risk factors play an important role in the development of symptoms and their severity, as well as responding to medications. A literature search was performed using fve keywords, namely COVID-19, diabetes, ethnicity, medications, and risk factors between January 2019 and December 2020 using electronic databases such as PubMed, Science Direct, Google Scholar, Springer Link, and Scopus. Forty studies were included. The review indicated that diabetes was a signifcant risk factor for poorer outcomes and increased mortality associated with COVID-19. There were several risk factors for diabetic patients that increased their likelihood of poorer outcomes associated with COVID-19. These included black and Asian ethnicity, male sex with high BMI. In conclusion, patients with diabetes of black or Asian origin with high BMI, male sex, and older age had an increased risk of poorer outcomes associated with COVID-19. This highlights the importance of considering the history of the patient in prioritising care and treatment.
| Type: | Article |
|---|---|
| Title: | COVID-19 and diabetes in 2020: a systematic review |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1186/s40545-023-00546-z |
| Publisher version: | https://doi.org/10.1186/s40545-023-00546-z |
| Language: | English |
| Additional information: | © The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| Keywords: | COVID-19, Diabetes, Ethnicity, Risk factors |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10166309 |
Archive Staff Only
 |
View Item |
